Organization · Angel Group
IAB - Italian Angels for Biotech
IAB - Italian Angels for Biotech is an angel investment association based in Milan, focused on funding early-stage life sciences startups. Established in 2015, it connects scientific talent with business opportunities in the biotech sector.
Overview
What IAB - Italian Angels for Biotech does
What IAB - Italian Angels for Biotech is
IAB - Italian Angels for Biotech is an angel investment association based in Milan, focused on funding early-stage life sciences startups. Established in 2015, it connects scientific talent with business opportunities in the biotech sector.
How it participates in the startup ecosystem
The current public profile supports funder and community capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Angel Group
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder · Community
- Last reviewed
- April 11, 2026
Official channels
Find IAB - Italian Angels for Biotech elsewhere
Open the official website or a supported primary organization account.
Capability profile
IAB - Italian Angels for Biotech as a funder
Investment thesis
IAB aims to identify and nurture talented entrepreneurs in Life Sciences by leading equity investments to help startups reach their objectives.
Focus narrative
IAB invests broadly in early-stage Life Sciences projects, including drug discovery and development, advanced therapies, diagnostics and reagents, medical devices, medical equipment, biomaterials, nutraceuticals, and veterinary products. The organization emphasizes the importance of mentoring and networking, connecting startups with venture capitalists, industry experts, and service providers.
Value beyond capital
IAB provides valuable mentoring and networking opportunities, connecting startups with venture capitalists, industry experts, and service providers to enhance their growth and success.
Terms and economics
- Typical check
- $500,000–$1,800,000
- Sweet spot
- $1,000,000
Focus and fit
- Stages
- Angel · Pre-seed · Seed
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 3
Portfolio context
Notable investments include Utopia SiS, which received €1.8 million for new therapies for Alzheimer's treatment; MgShell, a MedTech company that closed a €500,000 investment round for innovative treatments for macular degeneration; and Metis Precision Medicine, which received €800,000 to support the development of innovative cancer therapies.
Capability profile
IAB - Italian Angels for Biotech as a community
Community overview
Italian Angels for Biotech (IAB) is an association founded in mid-2015 by a group of experienced professionals in the Life Sciences sector. Based in Bresso, Italy, IAB aims to identify and nurture talented entrepreneurs in Life Sciences by leading equity investments to help startups reach their objectives.
Community focus
IAB invests broadly in early-stage Life Sciences projects, including drug discovery and development, advanced therapies, diagnostics and reagents, medical devices, medical equipment, biomaterials, nutraceuticals, and veterinary products. The organization emphasizes the importance of mentoring and networking, connecting startups with venture capitalists, industry experts, and service providers.
Member value
Members benefit from networking opportunities, mentorship, and access to a community of experienced professionals in the Life Sciences sector. The organization also facilitates connections with venture capitalists and industry experts to support startup growth.
Membership
- Pricing models
- free
Format and cadence
- Modality
- in-person
- Schedule
- rolling-admissions
- Commitment
- light
Availability
- Membership state
- Accepting
Audience and fit
- Audience
- Founders · Investors
- Benefits
- mentorship and network-access
- Program types
- community and bootcamp
- Selection criteria
- open
- Stages
- Pre-seed · Seed
- Sectors
- Biotech & Life Sciences
- Regions
- Europe
Community activity
- Annual events
- 4
Events and activity
IAB organizes several events, including the IAB Elevator Pitch, which consists of four events per year where startups present their projects to IAB members, and TT2 Value workshops focused on technology transfer in Life Sciences.
Notable members
Key team members include Alessandro Crevani, General Manager at Sanofi Italy and Malta; Alessandro Lattuada, Managing Director at Otsuka Pharmaceutical; and Chiara Zambon, Vice-President of Zambon Company S.p.A.
Common questions
What to know about IAB - Italian Angels for Biotech
Upseed classifies IAB - Italian Angels for Biotech under the Angel Group organization type. Its current public profile includes funder and community capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 11, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.